Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362514615> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4362514615 abstract "<p>PDF - 243KB, Supplementary Figure S1. Growth inhibition of TAS-115 against MET amplified cancer cell lines. Supplementary Figure S2. Kinase inhibitor-induced cell damage in rat cardiomyocytes after 96 h of treatment. Supplementary Figure S3. Gene expression changes in mice bearing human gastric cancer SC-9 after TAS-115 or sunitinib treatment. Supplementary Figure S4. Anti-tumor efficacy of TAS-115 against athymic mice transplanted with MET-amplified human gastric cancer Hs746T (A), NUGC-4 (B). Supplementary Figure S5. The inhibitory activity of sunitinib against adenosine monophosphate (AMP)-activated protein kinase (AMPK). Supplementary Table S1. Kinase inhibitory activity of TAS-115 and sunitinib against 192 kinases. Supplementary Table S2. Cell growth inhibition of TAS-115, sunitinib, sorafenib and crizotinib against MET-amplified or MET-inactivated cancer cell lines. Supplementary Table S3. Median survival times (MST) in the NUGC-4 peritoneal dissemination model after TAS-115 or sunitinib treatment.</p>" @default.
- W4362514615 created "2023-04-06" @default.
- W4362514615 creator A5003458956 @default.
- W4362514615 creator A5004282323 @default.
- W4362514615 creator A5006225110 @default.
- W4362514615 creator A5009759451 @default.
- W4362514615 creator A5012844460 @default.
- W4362514615 creator A5023909429 @default.
- W4362514615 creator A5025302913 @default.
- W4362514615 creator A5033575191 @default.
- W4362514615 creator A5038408644 @default.
- W4362514615 creator A5039089946 @default.
- W4362514615 creator A5052200954 @default.
- W4362514615 creator A5058224843 @default.
- W4362514615 creator A5058428375 @default.
- W4362514615 creator A5063302620 @default.
- W4362514615 creator A5066075937 @default.
- W4362514615 creator A5067486875 @default.
- W4362514615 creator A5073803847 @default.
- W4362514615 creator A5087098741 @default.
- W4362514615 date "2023-04-03" @default.
- W4362514615 modified "2023-09-27" @default.
- W4362514615 title "Supplementary Figures 1 through 5 and Supplementary Tables 1 through 3 from The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked <i>In Vivo</i> Antitumor Properties and a Favorable Tolerability Profile" @default.
- W4362514615 doi "https://doi.org/10.1158/1535-7163.22497534.v1" @default.
- W4362514615 hasPublicationYear "2023" @default.
- W4362514615 type Work @default.
- W4362514615 citedByCount "0" @default.
- W4362514615 crossrefType "posted-content" @default.
- W4362514615 hasAuthorship W4362514615A5003458956 @default.
- W4362514615 hasAuthorship W4362514615A5004282323 @default.
- W4362514615 hasAuthorship W4362514615A5006225110 @default.
- W4362514615 hasAuthorship W4362514615A5009759451 @default.
- W4362514615 hasAuthorship W4362514615A5012844460 @default.
- W4362514615 hasAuthorship W4362514615A5023909429 @default.
- W4362514615 hasAuthorship W4362514615A5025302913 @default.
- W4362514615 hasAuthorship W4362514615A5033575191 @default.
- W4362514615 hasAuthorship W4362514615A5038408644 @default.
- W4362514615 hasAuthorship W4362514615A5039089946 @default.
- W4362514615 hasAuthorship W4362514615A5052200954 @default.
- W4362514615 hasAuthorship W4362514615A5058224843 @default.
- W4362514615 hasAuthorship W4362514615A5058428375 @default.
- W4362514615 hasAuthorship W4362514615A5063302620 @default.
- W4362514615 hasAuthorship W4362514615A5066075937 @default.
- W4362514615 hasAuthorship W4362514615A5067486875 @default.
- W4362514615 hasAuthorship W4362514615A5073803847 @default.
- W4362514615 hasAuthorship W4362514615A5087098741 @default.
- W4362514615 hasBestOaLocation W43625146151 @default.
- W4362514615 hasConcept C121608353 @default.
- W4362514615 hasConcept C126322002 @default.
- W4362514615 hasConcept C184235292 @default.
- W4362514615 hasConcept C2775930923 @default.
- W4362514615 hasConcept C2778019345 @default.
- W4362514615 hasConcept C2778695046 @default.
- W4362514615 hasConcept C2779490328 @default.
- W4362514615 hasConcept C2779744173 @default.
- W4362514615 hasConcept C502942594 @default.
- W4362514615 hasConcept C530470458 @default.
- W4362514615 hasConcept C71924100 @default.
- W4362514615 hasConcept C86803240 @default.
- W4362514615 hasConcept C95444343 @default.
- W4362514615 hasConcept C98274493 @default.
- W4362514615 hasConceptScore W4362514615C121608353 @default.
- W4362514615 hasConceptScore W4362514615C126322002 @default.
- W4362514615 hasConceptScore W4362514615C184235292 @default.
- W4362514615 hasConceptScore W4362514615C2775930923 @default.
- W4362514615 hasConceptScore W4362514615C2778019345 @default.
- W4362514615 hasConceptScore W4362514615C2778695046 @default.
- W4362514615 hasConceptScore W4362514615C2779490328 @default.
- W4362514615 hasConceptScore W4362514615C2779744173 @default.
- W4362514615 hasConceptScore W4362514615C502942594 @default.
- W4362514615 hasConceptScore W4362514615C530470458 @default.
- W4362514615 hasConceptScore W4362514615C71924100 @default.
- W4362514615 hasConceptScore W4362514615C86803240 @default.
- W4362514615 hasConceptScore W4362514615C95444343 @default.
- W4362514615 hasConceptScore W4362514615C98274493 @default.
- W4362514615 hasLocation W43625146151 @default.
- W4362514615 hasOpenAccess W4362514615 @default.
- W4362514615 hasPrimaryLocation W43625146151 @default.
- W4362514615 hasRelatedWork W2130073368 @default.
- W4362514615 hasRelatedWork W2168381076 @default.
- W4362514615 hasRelatedWork W2267046078 @default.
- W4362514615 hasRelatedWork W2590479703 @default.
- W4362514615 hasRelatedWork W2745136137 @default.
- W4362514615 hasRelatedWork W3015009229 @default.
- W4362514615 hasRelatedWork W3083665455 @default.
- W4362514615 hasRelatedWork W3149830425 @default.
- W4362514615 hasRelatedWork W32471882 @default.
- W4362514615 hasRelatedWork W4296794553 @default.
- W4362514615 isParatext "false" @default.
- W4362514615 isRetracted "false" @default.
- W4362514615 workType "article" @default.